WO2026125094 - ANTIBIOTIC COMPOUNDS FOR TREATING BACTERIAL INFECTIONS ASSOCIATED WITH A STAPHYLOCOCCAL SPECIES
National phase entry is expected:
Publication Number
WO/2026/125094
Publication Date
18.06.2026
International Application No.
PCT/EP2025/085275
International Filing Date
03.12.2025
Title **
[English]
ANTIBIOTIC COMPOUNDS FOR TREATING BACTERIAL INFECTIONS ASSOCIATED WITH A STAPHYLOCOCCAL SPECIES
[French]
COMPOSÉS ANTIBIOTIQUES POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES ASSOCIÉES À UNE ESPÈCE STAPHYLOCOCCIQUE
Applicants **
DEBIOPHARM INTERNATIONAL SA
Inventors
GERUSZ, Vincent
CAMERON, David
Priority Data
24219774.7
13.12.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2133 | |
| EPO | Filing, Examination, Granting | 8622 | |
| Japan | Filing, Examination, Granting | 2122 | |
| South Korea | Filing, Examination, Granting | 2008 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
20,825
Contact Us
Abstract[English]
The present invention provides compounds of general Formula (I) which are suitable for treating bacterial infections associated with a Staphylococcal species.[French]
La présente invention concerne des composés de formule générale (I) qui sont appropriés pour traiter des infections bactériennes associées à une espèce staphylococcique.